- Home
- TR vs HAE Comparison
TR vs HAE Comparison
Compare TR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- HAE
- Stock Information
- Founded
- TR 1896
- HAE 1971
- Country
- TR United States
- HAE United States
- Employees
- TR N/A
- HAE N/A
- Industry
- TR Specialty Foods
- HAE Medical/Dental Instruments
- Sector
- TR Consumer Staples
- HAE Health Care
- Exchange
- TR Nasdaq
- HAE Nasdaq
- Market Cap
- TR 2.9B
- HAE 3.3B
- IPO Year
- TR N/A
- HAE 1991
- Fundamental
- Price
- TR $38.66
- HAE $53.68
- Analyst Decision
- TR
- HAE Buy
- Analyst Count
- TR 0
- HAE 11
- Target Price
- TR N/A
- HAE $86.73
- AVG Volume (30 Days)
- TR 184.2K
- HAE 1.1M
- Earning Date
- TR 07-24-2025
- HAE 08-07-2025
- Dividend Yield
- TR 0.94%
- HAE N/A
- EPS Growth
- TR N/A
- HAE 46.89
- EPS
- TR 1.24
- HAE 3.28
- Revenue
- TR $722,849,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- TR N/A
- HAE N/A
- Revenue Next Year
- TR N/A
- HAE $7.26
- P/E Ratio
- TR $31.16
- HAE $16.40
- Revenue Growth
- TR N/A
- HAE 0.91
- 52 Week Low
- TR $27.14
- HAE $50.68
- 52 Week High
- TR $40.43
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- TR 55.04
- HAE 25.17
- Support Level
- TR $38.31
- HAE $51.47
- Resistance Level
- TR $40.03
- HAE $54.06
- Average True Range (ATR)
- TR 0.89
- HAE 2.96
- MACD
- TR -0.15
- HAE -2.21
- Stochastic Oscillator
- TR 47.83
- HAE 11.47
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.